IMMUNOSUPPRESSIVE TREATMENT OF HBSAG-POSITIVE CHRONIC LIVER-DISEASE - SIGNIFICANCE OF HBEAG

被引:6
作者
TAGEJENSEN, U
ALDERSHVILE, J
SCHLICHTING, P
机构
[1] KOMMUNE HOSP,DEPT MED 2,DK-1399 COPENHAGEN,DENMARK
[2] RIGSHOSP,DEPT MED A,DK-2100 COPENHAGEN O,DENMARK
[3] RIGSHOSP,DEPT INFECT DIS,DK-2100 COPENHAGEN O,DENMARK
[4] SKT ELISABETH HOSP,DEPT MED,COPENHAGEN,DENMARK
[5] HVIDOVRE HOSP,DIV HEPATOL,COPENHAGEN,DENMARK
[6] HVIDOVRE HOSP,DEPT PATHOL,COPENHAGEN,DENMARK
关键词
D O I
10.1002/hep.1840050111
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:47 / 49
页数:3
相关论文
共 50 条
  • [31] T-LYMPHOCYTE-MEDIATED CYTOTOXICITY IN HBSAG-POSITIVE ACUTE AND CHRONIC LIVER-DISEASE - DEVELOPMENT OF A NEW ASSAY
    SHEIKH, NEL
    OSMAN, CG
    CULLENS, H
    EDDLESTON, ALWF
    WILLIAMS, R
    [J]. DIGESTION, 1976, 14 (5-6) : 549 - 550
  • [32] ANTIVIRAL THERAPY IN HBSAG-POSITIVE CHRONIC LIVER-DISEASE (HBSAG+VE-CLD) - HOW MANY PATIENTS DO REALLY NEED IT
    ASCIONE, A
    AMITRANO, L
    RICCIO, E
    DELELLA, A
    DEBELLIS, G
    DALESSANDRO, R
    FIORE, F
    PADULANO, P
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1982, 6 (10): : 817 - 817
  • [33] EFFECT OF IMMUNOSUPPRESSIVE THERAPY ON HBSAG-POSITIVE CHRONIC ACTIVE HEPATITIS IN RELATION TO PRESENCE OR ABSENCE OF HBEAG AND ANTI-HBE
    SAGNELLI, E
    PICCININO, F
    MANZILLO, G
    FELACO, FM
    FILIPPINI, P
    MAIO, G
    PASQUALE, G
    IZZO, CM
    [J]. HEPATOLOGY, 1983, 3 (05) : 690 - 695
  • [34] HLA-DR ANTIGENS IN HBSAG-POSITIVE CHRONIC ACTIVE LIVER-DISEASE WITH AND WITHOUT ASSOCIATED DELTA-INFECTION
    FORZANI, B
    ACTIS, GC
    VERME, G
    AMOROSO, A
    BORELLI, I
    CURTONI, ES
    RUMI, MG
    PICCIOTTO, A
    MARINUCCI, G
    FRENI, MA
    RIZZETTO, M
    [J]. HEPATOLOGY, 1984, 4 (06) : 1107 - 1110
  • [35] ACTIVATED LYMPHOCYTES-T IN HBSAG POSITIVE CHRONIC LIVER-DISEASE
    BANCHETTI, E
    AMBU, S
    SURRENTI, C
    ALVIGGI, L
    [J]. JOURNAL OF HEPATOLOGY, 1987, 5 : S87 - S87
  • [36] IMMUNOSUPPRESSIVE THERAPY IN CHRONIC LIVER-DISEASE
    SHERLOCK, S
    [J]. MINERVA MEDICA, 1978, 69 (38) : 2605 - 2609
  • [37] AFP IN HUMAN PREMALIGNANT LIVER-DISEASE - SERUM CONCENTRATIONS IN ASYMPTOMATIC HBSAG-POSITIVE BLOOD-DONORS
    KELLEHER, PC
    SMITH, CJP
    NATH, N
    DODD, RY
    [J]. TUMOUR BIOLOGY, 1985, 6 (04): : 399 - 399
  • [38] INEFFICACY OF IMMUNOSUPPRESSIVE TREATMENT IN HBSAG-POSITIVE, DELTA-NEGATIVE, MODERATE CHRONIC ACTIVE HEPATITIS IN CHILDREN
    VAJRO, P
    ORSO, G
    DANTONIO, A
    GRECO, L
    FONTANELLA, A
    LOFFREDO, G
    OGGERO, V
    BUFFOLANO, W
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1985, 4 (01) : 26 - 31
  • [39] CLINICAL-SIGNIFICANCE OF DELTA ANTIBODY IN HBSAG+ CHRONIC LIVER-DISEASE
    VALLEBONA, E
    SOLINAS, A
    FAA, G
    CARRUXI, R
    SANNA, G
    PITZUS, F
    DEMELIA, L
    [J]. JOURNAL OF HEPATOLOGY, 1987, 5 : S215 - S215
  • [40] DNA BINDING ANTIBODIES IN HBSAG POSITIVE AND NEGATIVE ACUTE AND CHRONIC LIVER-DISEASE
    KINGHAM, JGC
    GANGULY, NK
    HOLGATE, ST
    TRIGER, DR
    MCGUIRE, M
    COHEN, B
    RASSAM, S
    WRIGHT, R
    [J]. GUT, 1977, 18 (11) : A978 - A979